Novocure
Brooke Huang has extensive experience in the pharmaceutical and biotechnology industries, currently serving as Senior Vice President of Global Product & Portfolio Strategy at Novocure since April 2014. Previous roles at Novocure include Vice President and Head of Product Strategy, where responsibilities included aligning product strategies for new indications and enhancing market adoption of Optune. Before joining Novocure, Brooke held various positions at Daiichi Sankyo, managing global brand strategies for edoxaban and Effient, and was involved in medical affairs at Sanofi and Bristol-Myers Squibb. Brooke holds a Doctor of Pharmacy degree from Purdue University and has a solid foundation in marketing, brand management, and product launches within the oncology and cardiovascular sectors.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.